See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/47224905

Stockley’s drug interactions 2009 pocket companion

Article  in  Canadian family physician Médecin de famille canadien · January 2008

Source: PubMed Central

CITATIONS READS
0 308

1 author:

Dale Quest
Texas Tech University Health Sciences Center, El Paso, Texas, United States
41 PUBLICATIONS   277 CITATIONS   

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

preeclampsia View project

diabetes education View project

All content following this page was uploaded by Dale Quest on 29 October 2015.

The user has requested enhancement of the downloaded file.

Book Reviews
anesthetics, specialist use of mul-
Stockley’s drug tidrug antiviral treatments, and

interactions
antineoplastic regimens. Editions
are being published in yearly suc-

2009 pocket cession, but even at the time of

print a number of new interactions,

companion such as reduced efficacy of clopi-

dogrel with proton pump inhibi-
tors or selective serotonin reuptake
EDITOR  Karen Baxter inhibitors interfering with tamoxi-
PUBLISHER  Pharmaceutical Press, fen, have appeared in Lexi-Interact
1 Lambeth High St, London updates and the Canadian version
SE1 7JN, United Kingdom of The Medical Letter on Drugs and
TELEPHONE  44 (0)20 7735 9141 Therapeutics.1,2
FAX  44 (0)20 7572 2509 Much like the drug-interactions
WEBSITE  www.pharmpress.com component of integrated hand-
PUBLISHED  2009/459 pp/$45.95 held electronic programs, such as
Lexi-Comp drug information soft-
OVERALL RATING  Good ware (www.lexi.com), this hard-
information on interactions among copy reference provides quite
STRENGTHS  Thoroughly
pharmaceuticals, several herbal current information about the puta-
researched, evidence-
products, and dietary supplements. tive mechanism, nature, frequency,
based, rationally organized,
More than 1500 monographs are and seriousness of drug interac-
an enduring product of cross-referenced alphabetically tions, including suggestions on how
the Royal Pharmaceutical according to nonproprietary names to accommodate those interactions
Society of Great Britain and US approved names where those with potentially safer drug choices.
WEAKNESSES  Targeted to differ. Canadians must bear such Although in competition with its
British and US audiences; nuances in mind, as acetaminophen regularly updated electronic hand-
its utility and shelf-life are is called paracetamol; meperidine held counterparts, this little book is
diminished by constantly is called pethedine; and cyclospo- reasonably priced and works with-
updated hand-held elec- rine is spelled ciclosporin. The book out batteries.
tronic resources lists drugs that are not available in —Dale W. Quest PhD
Canada; conversely, some drugs
AUDIENCE  Health profes- Dr Quest is an Associate Professor of Medical
that are marketed in Canada are
sionals who prescribe and Education in the Paul L. Foster School of Medicine
not included. The compact dimen- at the Texas Tech University Health Science Center
evaluate drug therapy in El Paso.
sions of the physical book (10.5 cm
× 18.5 cm × 2.5 cm) are maintained References

T his compact reference provides
practitioners with ready access
to clinically relevant evidence-based
by locating the references on-line
(http://medicinescomplete.com)
and by omitting interactions involving
1. In brief: tamoxifen and SSRI interaction. Med Lett
Drugs Ther 2009;51(1314):45.
2. Milnacipran (savella) for fibromyalgia. Med Lett
Drugs Ther 2009;51(1314):45-6.

e86  Canadian Family Physician • Le Médecin de famille canadien  Vol 56:  february • février 2010

View publication stats